Alaunos Therapeutics | ZIOP - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Baxter International USD 6.87B 61M 2025-12
Biogen USD 8.97B 37.5M 2025-12
Bioline Rx USD 28.52M 3.34M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Celltrion KRW 5.54T 291.68B 2025-09
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Curis USD 6.92M 7.5M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Divis Laboratories Ltd INR 98.43B 2.38B 2025-09
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Incyte USD 5.48B 460.36M 2026-03
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
J&J USD 59.17B 3.55B 2026-03
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Merck USD 47.56B 10.49B 2025-09
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pfizer USD 46.92B 3.22B 2025-09
Pharma Mar EUR 283.41M 40.53M 2025-12
PTC Therapeutics USD 2.27B 266.14M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
TG Therapeutics USD 630.76M 31M 2025-12
Tilray USD 729.32M 28.18M 2025-09
Verastem USD 223.41M 69.36M 2025-12
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 10.7B 1.59B 2025-09